Respiratory conditions

Tracheobronchomalacia

The windpipe and main airways are floppy, and squeeze shut when you breathe out hard or cough. It produces a distinctive barking cough and a feeling of not being able to shift mucus — and, unusually, the harder you cough the less well it works.

For patients & health professionals
Tetralogy of Fallot A–Z of Conditions · 76 of 86 Tuberculosis
Authorship & review
Dr Sean James Ledger, BSc Physio (Hons) MSc PhD FHEA
Director and Principal Physiotherapist
Ahpra registration PHY0002298174
Version
1.0
Last updated
12 August 2026
Next review
12 August 2027
Every guide on this site is reviewed at least once a year, and sooner when the evidence changes.
How these guides are written and reviewed →
Part 1 · In plain language

The windpipe and the two main airways below it normally hold their shape because they are supported by rings of cartilage. In tracheobronchomalacia that support is weak, or the soft back wall bulges forward, so the airway narrows or closes when you breathe out hard, cough, laugh or strain. The typical symptoms are a barking or seal-like cough, breathlessness on exertion, noisy breathing, repeated chest infections, and the frustrating sense that mucus is stuck and coughing will not shift it. The important and counterintuitive part is that forcing the cough makes it worse, because the harder you push the more the airway collapses. Techniques that hold the airway open — breathing out gently against slight resistance, huffing at low effort — work far better than trying harder.

Definition

Tracheobronchomalacia is excessive narrowing of the trachea and main bronchi during expiration, caused by weakness of the airway wall. Two mechanisms are grouped under the term, and they are worth separating because they look different at bronchoscopy:

MechanismWhat happensNote
True malaciaThe cartilage itself is soft or deficient, so the whole airway circumference collapsesCongenital forms, relapsing polychondritis, post-tracheostomy
Excessive dynamic airway collapseCartilage is normal; the soft posterior membrane bulges forward into the lumenMuch the commoner form in adults, and strongly associated with COPD and obesity

Severity is described by the percentage reduction in cross-sectional area on expiration, though the thresholds are contested — a substantial proportion of healthy people narrow considerably on a forced manoeuvre, which is why the finding must be interpreted against symptoms rather than in isolation.

Pathophysiology

Why breathing out is the problem

During quiet breathing, pressure inside the central airway keeps it open. During forced expiration, coughing or straining, pleural pressure rises above airway pressure and squeezes the airway from outside. A normal airway resists this because its cartilage is stiff; a malacic one does not, and collapses. The result is expiratory flow limitation in the large airways — a different mechanism from the small-airway limitation of COPD, although the two frequently coexist.

The cough paradox

Effective cough depends on high expiratory flow through an open airway. In tracheobronchomalacia, greater expiratory effort produces greater collapse, so beyond a certain point additional effort reduces flow at the point where it is needed. Patients discover this themselves — they describe coughing repeatedly and exhaustingly without clearing anything — and the observation is the foundation of the physiotherapy management.1

Consequences

Retained secretions follow, then recurrent infection, and in some patients bronchiectasis. Exertional breathlessness reflects both flow limitation and the work of breathing against a collapsing airway. Severe cases can produce cough syncope, where the pressure generated during a coughing bout reduces cardiac output enough to cause a faint.

Co-morbidities

Prevalence

Genuinely unknown, and almost certainly under-recognised. It is not looked for unless someone thinks of it, and the dynamic collapse that defines it is invisible on standard inspiratory CT. Reported frequencies in patients investigated for chronic cough or COPD vary enormously depending on the imaging protocol and the diagnostic threshold used. What is reasonably clear is that it is commoner in older adults, in obesity, and in advanced COPD, and that many patients carry a diagnosis of difficult asthma or refractory COPD for years before the airway collapse is identified.2

Causes

Symptoms

The characteristic picture

Warning signs

Call 000 nowSudden severe breathlessness with stridor at rest, blue lips, or fainting during coughing. Severe central airway collapse can obstruct acutely.
Emergency department todayAn inability to clear a plug of mucus despite treatment.

Diagnosis

Why it is missed

The diagnosis depends on imaging the airway while the patient breathes out. Standard CT is taken at full inspiration, when a malacic airway looks entirely normal. Spirometry may be normal or show non-specific obstruction, and bronchodilators do not help — so patients are commonly labelled as having difficult asthma or refractory COPD instead.

How it is diagnosed

Interpreting the result

Collapse on imaging is not automatically the explanation for the symptoms. Healthy people narrow substantially on forced expiration, and the older diagnostic thresholds label a significant proportion of normal subjects as abnormal. The finding earns its place only when the degree of collapse fits the clinical picture and other causes have been addressed.3

Management

Treat what is treatable first

Most patients improve substantially without any airway-directed intervention. Optimising COPD or asthma treatment, treating reflux, weight loss where obesity contributes, treating sleep apnoea, smoking cessation, and vigorous treatment of infection between them account for much of the achievable benefit, and are the necessary first phase in every case.

Positive airway pressure

CPAP acts as a pneumatic splint, holding the central airway open during expiration. It is used at night in patients with coexisting sleep apnoea, and occasionally during the day or during airway clearance in more severe disease. For many patients this is the intervention that changes daily function most.

Airway clearance

Detailed below under the physiotherapist’s role, because it is where technique choice matters more than in almost any other airway condition.

Stents and surgery

Airway stenting is used mainly as a short-term trial to establish whether relieving the collapse actually improves symptoms, rather than as a long-term solution — complication rates with prolonged stenting are high. Tracheobronchoplasty, in which the posterior membrane is splinted surgically, produces good results in carefully selected patients at specialist centres, and a positive stent trial is usually required before it is considered.4

Living with tracheobronchomalacia

Unlearning the forceful cough

Most patients arrive having taught themselves to cough as hard as possible, because that is what works for everyone else. Learning that a gentler, more controlled technique clears more with less exhaustion takes practice and repeated reassurance — it feels wrong at first.

Positions and daily patterns

Many people find symptoms worse lying flat, bending forward, or after a large meal. Small adjustments — sleeping more upright, smaller meals, avoiding heavy lifting during a flare — are often more useful than they sound.

Infections

Chest infections are both more frequent and slower to clear. Having a plan — when to start increasing clearance, when to seek antibiotics, when to seek review — reduces both the length and the impact of each episode.

The diagnostic journey

Many patients have spent years being treated for asthma or COPD with medicines that did not help. Getting the diagnosis is often accompanied by frustration about the time it took; it is worth acknowledging rather than moving past.

Prognosis

Congenital malacia in infants generally improves as the cartilage stiffens with growth. In adults the condition is usually stable rather than progressive, and the trajectory is dominated by the associated conditions — COPD, obesity, recurrent infection — more than by the airway collapse itself. Well-selected patients who undergo tracheobronchoplasty report substantial and durable improvement in breathlessness and quality of life. The main avoidable harms are repeated ineffective treatment for a misdiagnosis, and progressive bronchiectasis from years of poor clearance.

Role of the physiotherapist

Assessment

Listen to the cough — the barking quality is diagnostic information available at no cost. Assess cough effectiveness at different efforts rather than at maximum only, sputum volume and the difficulty of clearing it, exertional tolerance and position dependence, and the patient’s current self-taught technique, which is usually what needs changing.

Clearance technique — the central intervention

The governing principle is to generate flow without generating collapse:

See huffing and coughing and airway clearance techniques for the underlying technique, applied here at deliberately lower effort.

Exercise

Exertional breathlessness responds to training as it does elsewhere, and deconditioning is a major contributor. Use pursed-lip breathing during effort, expect symptoms to be worse in positions that compress the chest, and progress on symptoms. Where COPD coexists, standard pulmonary rehabilitation applies with the clearance modifications above.

Education

The single most valuable message is the cough paradox: harder is not better. Patients who understand why gentle technique works are far more likely to persist with something that initially feels inadequate.

Part 1 · References

  1. Murgu SD, Colt HG. Tracheobronchomalacia and excessive dynamic airway collapse. Respirology 2006;11(4):388–406.
  2. Buitrago DH, Wilson JL, Parikh M, Majid A, Gangadharan SP. Current concepts in severe adult tracheobronchomalacia: evaluation and treatment. J Thorac Dis 2017;9(1):E57–E66.
  3. Boiselle PM, Michaud G, Roberts DH, et al. Dynamic expiratory tracheal collapse in COPD: correlation with clinical and physiologic parameters. Chest 2012;142(6):1539–1544.
  4. Ernst A, Odell DD, Michaud G, et al. Central airway stabilization for tracheobronchomalacia improves quality of life in patients with COPD. Chest 2011;140(5):1162–1168.

References are numbered in citation order (Vancouver/BMJ style) and were current at the time of writing. Guidelines are living documents — verify against the latest version before clinical use.

How we treat this at the clinic

More than one of our services applies here, and which combination suits you depends on what your assessment shows.

Part 2 of 2

Clinical evidence

Part 1 covers the same condition without the technical detail. What follows is the evidence base behind it, written for clinicians — the literature, the reasoning and the gaps.

For clinicians: this summary supports clinical reasoning and is not a protocol. Check current guidelines and local policy before applying it, and read it alongside the key references and guidelines directory.

Framing. Two problems shape practice. The first is diagnostic: expiratory central airway collapse exceeding the conventional 50% threshold occurs in a substantial proportion of asymptomatic healthy adults, so the imaging finding is not the disease.1 The second is therapeutic: the interventional literature is almost entirely uncontrolled case series from a small number of specialist centres, in patients selected by symptom burden and by response to a stent trial — a selection process that is itself doing much of the work.2

Treatment evidence

  • Optimising coexisting disease comes first, and accounts for much of the achievable benefit. COPD and asthma treatment, reflux management, weight reduction, treatment of sleep apnoea and smoking cessation are the first phase in every published series; patients who improve on these are not offered intervention.2
  • CPAP as a pneumatic splint is supported by physiological studies showing improved expiratory flow, secretion clearance and exercise tolerance with applied positive pressure. Evidence is small-series and physiological rather than outcome-based, but the mechanism is direct and the intervention is low-risk.3
  • Stent trials are diagnostic, not therapeutic. A short-term silicone stent placement establishes whether relieving the collapse improves symptoms, and predicts benefit from surgery. Long-term stenting is avoided — migration, granulation, obstruction and infection rates are high enough that the FDA issued a specific warning against metallic stents in benign airway disease.4
  • Tracheobronchoplasty improves quality of life, dyspnoea scores and functional capacity in reported series from high-volume centres, sustained at follow-up. There is no randomised comparison, no sham control, and the results apply to a heavily selected population that has already passed a stent trial.2,5
  • Airway clearance evidence is mechanistic rather than trial-based. Positive expiratory pressure devices raise intraluminal pressure during expiration and are recommended on that physiological reasoning; no randomised trial has compared clearance strategies in this population.3
  • Bronchodilators are of limited value and may theoretically worsen collapse by reducing airway smooth muscle tone. They are retained where obstructive disease coexists, not for the malacia itself.

Clinical reasoning

  • The 50% threshold is not a diagnosis. Boiselle's healthy-volunteer data found expiratory collapse above that level in a large share of normal subjects during forced expiration. Interpret the degree of collapse against symptoms, and against what else has already been treated — not as a stand-alone criterion.1
  • Request the expiratory acquisition explicitly. A standard inspiratory CT will report a normal airway in a patient with severe malacia. This is the single commonest reason the diagnosis is missed.
  • Bronchoscopy must be performed on a spontaneously breathing, lightly sedated patient. Deep sedation, paralysis or positive-pressure ventilation abolishes the finding — a normal bronchoscopy under general anaesthesia does not exclude the diagnosis.
  • The barking cough and bronchodilator non-response are the clinical discriminators from asthma and COPD, and are available before any imaging. A patient with a brassy cough labelled “refractory asthma” deserves the question.
  • Forced expiration technique is contraindicated as conventionally taught. The flow–collapse relationship means maximal expiratory effort reduces flow at the point of obstruction. Teach low-effort huffing at mid-to-low lung volume, PEP, and pursed-lip breathing; explicitly unteach the forceful cough patients have usually developed.
  • Cough syncope is a red flag, not a curiosity — it indicates pressure swings sufficient to compromise cardiac output and warrants specialist referral.
  • Expect coexisting bronchiectasis where clearance has been ineffective for years, and treat it on its own terms.

Evidence gaps

  • No agreed diagnostic threshold. Percentage-collapse criteria derived from small series perform poorly against healthy-volunteer data, and no symptom-anchored definition has been validated.
  • Prevalence is unknown in every relevant population, because ascertainment depends entirely on whether dynamic imaging was performed.
  • Tracheobronchoplasty has never been compared with optimised conservative management in a controlled design; the stent trial that selects patients also confounds the outcome.
  • No trial has compared airway clearance strategies. PEP, low-effort huffing and CPAP-assisted clearance are all recommended on physiological grounds alone.
  • The natural history in adults is poorly described — whether untreated dynamic collapse progresses, remains stable, or tracks the underlying COPD is unresolved.
  • Excessive dynamic airway collapse and true cartilaginous malacia are grouped together in most series despite different mechanisms, obscuring whether they respond differently to the same interventions.

References for the clinical evidence summary

  1. Boiselle PM, O'Donnell CR, Bankier AA, et al. Tracheal collapsibility in healthy volunteers during forced expiration: assessment with multidetector CT. Radiology 2009;252(1):255–262.
  2. Buitrago DH, Wilson JL, Parikh M, Majid A, Gangadharan SP. Current concepts in severe adult tracheobronchomalacia: evaluation and treatment. J Thorac Dis 2017;9(1):E57–E66.
  3. Murgu SD, Colt HG. Tracheobronchomalacia and excessive dynamic airway collapse. Respirology 2006;11(4):388–406.
  4. Ernst A, Majid A, Feller-Kopman D, et al. Airway stabilization with silicone stents for treating adult tracheobronchomalacia: a prospective observational study. Chest 2007;132(2):609–616.
  5. Ernst A, Odell DD, Michaud G, et al. Central airway stabilization for tracheobronchomalacia improves quality of life in patients with COPD. Chest 2011;140(5):1162–1168.
Important: This page is general information, not medical advice. If your breathing or symptoms change suddenly or severely, seek urgent medical care. For personalised assessment, contact Inspire Clinic.

Corrections: If something on this page is wrong, out of date or unclear, we want to know. Email reception@inspireclinic.au with the page name and what you believe is incorrect. Substantive corrections are made promptly, and the guide’s version and last-updated date are changed to reflect it.